Felicia Chow

Felicia Chow is a Clinical Associate Professor in the Department of Neurology at the University of California, San Francisco (UCSF). Her work focuses on HIV-associated neurological complications, particularly cerebrovascular disease and TB meningitis in resource-limited settings. She leads clinical trials investigating therapeutic regimens for TB meningitis in HIV-positive patients in Uganda and co-chairs an AIDS Clinical Trials Group multisite trial. She maintains an active clinical practice at Zuckerberg San Francisco General Hospital and directs the Neuro-Infectious Diseases Clinic embedded within UCSF's Infectious Diseases Clinic. Her research emphasizes biomarker development for neurocognitive decline, stroke risk in HIV populations, and global health equity in neurological care.

Her clinical expertise spans neurology and neuro-infectious diseases, with subspecialty training in infectious diseases. She provides specialized care for complex cases of CNS infections, including TB meningitis management. Her recent work examines sex differences in stroke risk among HIV patients and the impact of early ART initiation on neurological outcomes.

Key research contributions include studies on neurofilament light chain as a biomarker, cocaine/alcohol co-use in stroke risk, and global equity in neurological practice. She has advanced diagnostic criteria for Lyme disease and proposed novel therapeutic strategies for TB meningitis. Her work bridges clinical care, research, and global health advocacy.